This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Akiko Kanda: Innovator in Monoclonal Antibody Research
Introduction
Akiko Kanda is a prominent inventor based in Hyogo, Japan. She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. Her work has implications for diagnosing various medical conditions, including articular rheumatism and cancers.
Latest Patents
Kanda holds a patent for a monoclonal antibody that recognizes membrane phospholipase A₂. This invention includes monoclonal antibodies PL-49, PL-71, PL-76, and PL-78, along with hybridomas that produce them. The immunoassays developed using these antibodies are valuable tools for diagnosing a wide variety of inflammatory states.
Career Highlights
Throughout her career, Akiko Kanda has been associated with Shionogi Company Limited, where she has contributed to groundbreaking research. Her innovative work has led to advancements in the understanding and diagnosis of inflammatory diseases.
Collaborations
Kanda has collaborated with notable colleagues, including Nobuo Yoshida and Masao Kono, to further her research efforts. These collaborations have enhanced the impact of her work in the scientific community.
Conclusion
Akiko Kanda's contributions to monoclonal antibody research exemplify her dedication to advancing medical science. Her innovative patents and collaborations continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile